Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment.
- Resource Type
- Article
- Source
- The Journal of Clinical Endocrinology & Metabolism; March 2021, Vol. 106 Issue: 4 pe1618-e1630, 13p
- Subject
- Language
- ISSN
- 0021972X; 19457197